CRISPR Therapeutics AG (CRSP)
42.22
-0.40
(-0.93%)
USD |
NASDAQ |
Nov 13, 16:00
42.20
-0.02
(-0.06%)
After-Hours: 19:59
CRISPR Therapeutics Enterprise Value : 2.635B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.635B |
| November 11, 2026 | 2.938B |
| November 10, 2026 | 2.880B |
| November 09, 2026 | 3.354B |
| November 06, 2026 | 3.356B |
| November 05, 2026 | 3.210B |
| November 04, 2026 | 3.522B |
| November 03, 2026 | 3.349B |
| November 02, 2026 | 3.349B |
| October 30, 2026 | 3.487B |
| October 29, 2026 | 3.762B |
| October 28, 2026 | 3.748B |
| October 27, 2026 | 3.492B |
| October 26, 2026 | 3.254B |
| October 23, 2026 | 3.291B |
| October 22, 2026 | 3.349B |
| October 21, 2026 | 3.398B |
| October 20, 2026 | 3.338B |
| October 19, 2026 | 3.354B |
| October 16, 2026 | 3.277B |
| October 15, 2026 | 3.497B |
| October 14, 2026 | 3.371B |
| October 13, 2026 | 3.359B |
| October 12, 2026 | 3.500B |
| October 09, 2026 | 3.678B |
| Date | Value |
|---|---|
| October 08, 2026 | 3.392B |
| October 07, 2026 | 3.577B |
| October 06, 2026 | 3.737B |
| October 05, 2026 | 4.061B |
| October 02, 2026 | 3.876B |
| October 01, 2026 | 3.877B |
| September 30, 2026 | 3.865B |
| September 29, 2026 | 3.832B |
| September 28, 2026 | 3.647B |
| September 25, 2026 | 3.661B |
| September 24, 2026 | 3.803B |
| September 23, 2026 | 3.809B |
| September 22, 2026 | 4.125B |
| September 21, 2026 | 4.057B |
| September 18, 2026 | 3.886B |
| September 17, 2026 | 3.960B |
| September 16, 2026 | 3.466B |
| September 15, 2026 | 3.429B |
| September 14, 2026 | 3.538B |
| September 11, 2026 | 3.418B |
| September 10, 2026 | 3.471B |
| September 09, 2026 | 3.586B |
| September 08, 2026 | 3.714B |
| September 04, 2026 | 3.812B |
| September 03, 2026 | 3.879B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | -111.44M |
| Revenue (Quarterly) | 12.67M |
| Total Expenses (Quarterly) | 124.11M |
| EPS Diluted (Quarterly) | -1.152 |
| Gross Profit Margin (Quarterly) | -259.0% |
| Profit Margin (Quarterly) | -879.6% |
| Earnings Yield | -11.24% |
| Normalized Earnings Yield | -10.96 |